More Noxopharm Ltd. news Noxopharm Ltd.ASX: NOX Veyonda Survival Advantage in LuPSMA Therapy Confirmed Aug 5, 2021 at 4:13 AM UTC · Issued by Noxopharm Ltd. As issuedPlain English Noxopharm Ltd has released a press release. View Attachment
